Director of Renal Surgery, Henry Ford Hospital Director of Urologic Oncology, Henry Ford West Bloomfield Hospital

Urology

Craig Rogers is an expert in the field of Urology. He went to Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He has 14 awards "Teaching Award Finalist", "CMS Meaningful Use Stage 1 Certification", "Video of the Year", "Winner", "Best Doctors in America", "Americas Top Urologists", "Top Doc Hour", "Abstract Award", "Urologic Oncology Research Training Scholar", "2nd Prize", "Prize Winner", "Top Resident Score", "Phi Kappa Phi National Honor Society" and "Academic Presidential Full Tuition Merit Scholarship". Craig G. Rogers, MD is a published doctor. He has 100 publications published. The most current publication "Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis." He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
• Urinary fistula after robotic partial nephrectomy: a multicenter analysis of 1791 patients.
• Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature.
• Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
• Non-modifiable factors and complications contribute to length of stay in Robot-Assisted Partial Nephrectomy.
• Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney.
• Trifecta and Optimal Peri-operative outcomes of Robotic and Laparoscopic Partial Nephrectomy In Surgical Treatment Of Small Renal Masses: A Multi-Institutional Study.
• Oncologic Outcomes at 10 Years Following Robotic Radical Prostatectomy.
• Evaluation of Renal Mass Biopsy Risk Stratification Algorithm to Robotic Partial Nephrectomy: Could a Biopsy Have Guided Management?
• Prostate tissue metal levels and prostate cancer recurrence in smokers.
• Robotic Retroperitoneal Partial Nephrectomy: A Step-by-Step Guide.
• Off-clamp Robot-assisted Partial Nephrectomy Preserves Renal Function: A Multi-institutional Propensity Score Analysis.
• Robot-assisted Partial Nephrectomy in Patients with Baseline Chronic Kidney Disease: A Multi-institutional Propensity Score-Matched Analysis.
• Positive Surgical Margins in Robot Assisted Partial Nephrectomy: A Multi-Institutional Analysis of Oncologic Outcomes (Leave No Tumor Behind).
• Practice Patterns And Outcomes For Open And Minimally Invasive Partial Nephrectomy Since The Introduction Of Robotic Partial Nephrectomy: Results From The Nationwide I...
• ROBOTIC ANATROPHIC NEPHROLITHOTOMY WITH RENAL HYPOTHERMIA FOR TREATING STAGHORN CALCULI.
• Outcomes and Predictors of Clinical T1 to Pathological T3a Tumor Up-Staging After Robotic Partial Nephrectomy: A Multi-Institutional Analysis.
• Comparison of Robotic and Laparoscopic Ultrasound Probes for Robotic Partial Nephrectomy.
• Perioperative Complications of Robot-assisted Partial Nephrectomy: Analysis of 886 Patients at 5 United States Centers.
• Robotic partial nephrectomy with cold ischemia and on-clamp tumor extraction: recapitulating the open approach.
• Robotic ultrasound probe for tumor identification in robotic partial nephrectomy: Initial series and outcomes.
• Robotic partial nephrectomy for solitary kidney: a multi-institutional analysis.
• Tumor complexity predicts malignant disease for small renal masses.
• Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.
• Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample.
• Discharge patterns after radical prostatectomy in the United States of America.
• Multi-institutional Analysis of Robotic Partial Nephrectomy for Renal Tumors > 4cm vs. ??? 4cm in 445 Consecutive Patients.
• Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
• Does partial nephrectomy at an academic institution result in better outcomes?
• Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
• Open radical prostatectomy in the elderly: a case for concern?
• The effect of insurance status on outcomes after partial nephrectomy.
• Morbidity and mortality of radical prostatectomy differs by insurance status.
• Complications after robotic partial nephrectomy at centers of excellence: multi-institutional analysis of 450 cases.
• Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer.
• Anastomosis During Robot-assisted Radical Prostatectomy: Randomized Controlled Trial Comparing Barbed and Standard Monofilament Suture.
• Successful Total Robotic-Assisted Aortobifemoral Bypass for Treatment of Complicated Aortoiliac Occlusive Disease.
• Robot-assisted partial nephrectomy.
• Robotic partial nephrectomy in the setting of prior abdominal surgery.
• A novel method of urethrovesical anastomosis during robot-assisted radical prostatectomy using a unidirectional barbed wound closure device: feasibility study and earl...
• The impact of previous inguinal or abdominal surgery on outcomes after robotic radical prostatectomy.
• Robot-assisted management of congenital renal abnormalities in adult patients.
• Robotic partial nephrectomy: a comparison to current techniques.
• Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes.
• Combined robotic-assisted laparoscopic partial nephrectomy and radical prostatectomy.
• Microarray gene expression profiling using core biopsies of renal neoplasia.
• Maximizing console surgeon independence during robot-assisted renal surgery by using the Fourth Arm and TilePro.
• Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis.
• A novel technique for creating solid renal pseudotumors and renal vein-inferior vena caval pseudothrombus in a porcine and cadaveric model.
• Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy.
• Concurrent robotic partial adrenalectomy and extra-adrenal pheochromocytoma resection in a pediatric patient with von Hippel-Lindau disease.
• CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.
• Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
• Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
• Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
• Age stratified functional outcomes after laparoscopic radical prostatectomy.
• Nomograms provide improved accuracy for predicting survival after radical cystectomy.
• High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
• Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
• Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
• Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
• Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph no...
• A molecular classification of papillary renal cell carcinoma.
• Gene expression profiling of renal cell carcinoma and clinical implications.
• Carcinosarcoma of the prostate with urothelial and squamous components.
• Comparison of erbium:yttrium-aluminum-garnet and holmium:yttrium-aluminum-garnet lasers for incision of urethra and bladder neck in an in vivo porcine model.
• Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
• Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
• Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.
• Gene expression profiling of renal cell carcinoma.
• High-grade renal injuries in children--is conservative management possible?
• Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results.
• Extraosseous (extramedullary) plasmacytoma of the adrenal gland.
• Adenofibroma of the testis discovered at exploration for torsion after trauma.
• Robotic partial nephrectomy: surgical technique.
• Computer-assisted robotic renal surgery.
• Multi-institutional analysis of robotic partial nephrectomy for hilar versus nonhilar lesions in 446 consecutive cases.
• Expanding the indications of partial nephrectomy.
• Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
• The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications.
• Reply from authors re: Ricardo Brandina, Inderbir S. Gill. Robotic partial nephrectomy: new beginnings. Eur Urol 2010;57:778-9.
• Robot-assisted partial nephrectomy: an international experience.
• Robotic partial nephrectomy for renal tumors larger than 4 cm.
• Robotic-assisted partial nephrectomy: Has it come of age?
• Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
• Robotic-assisted partial nephrectomy.
• Open to debate. The motion: Robotic partial nephrectomy is better than open partial nephrectomy.
• Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.
• Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
• Robotic partial nephrectomy for complex renal tumors: surgical technique.
• Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
• Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
• Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
• Precystectomy nomogram for prediction of advanced bladder cancer stage.
• Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
• Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
• Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome.
• Robot-assisted partial nephrectomy in obese patients.
• Barbed suture for renorrhaphy during robot-assisted partial nephrectomy.

Schools

---

• Stanford University

• Johns Hopkins Hospital

• National Cancer Institute

Procedures Preformed

---

• Adrenalectomy
• Adrenalectomy With Robotic Assistance
• Advanced Robotic Surgery
• Bladder Surgery, Robotic-Assisted
• View All

Doctors Specialties

---

• Robotic Surgery
• Urologic Oncology
• Urology

Accepted Insurances

---

Awards

---

• Teaching Award Finalist
• CMS Meaningful Use Stage 1 Certification
• Video of the Year
• Winner
• “Best Doctors in America”
• “America’s Top Urologists”
• “Top Doc” Hour
• Abstract Award
• Urologic Oncology Research Training Scholar
• 2nd Prize
• Prize Winner
• Top Resident Score
• Phi Kappa Phi National Honor Society
• Academic Presidential Full Tuition Merit Scholarship

Education

---

• Johns Hopkins University
• Stanford University School of Medicine

Hospital

---

• Henry Ford Hospital

Drug Facts

---

NPI NUMBER		1689602815
NPPES Provider LastName		ROGERS
NPPES Provider FirstName		CRAIG
NPPES Provider ZIPCode		482022608
NPPES Provider State		MI
Specialty Description		Urology
Total Claim Count		185.0
Distinct Opioid Count		1.0
Opioid Claim Count		19.0
Percent Opioid Claims		10.27

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1689602815
Last Name Of The Provider	ROGERS
First Name Of The Provider	CRAIG
View All

Similar Doctors

---

	Dr. Ramarao Kaza, MD This Doctor is OpenDoctor Recommended.
	Dr. Bartosz F. Kaczmarek, MD
	Dr. Mani Menon, MD This Doctor is OpenDoctor Recommended.
	Dr. James O. Peabody, MD This Doctor is OpenDoctor Recommended.
	Dr. Hans J. Stricker, MD This Doctor is OpenDoctor Recommended.
	Dr. Yegappan Lakshmanan, MD This Doctor is OpenDoctor Recommended.
	Dr. Ray H. Littleton, MD This Doctor is OpenDoctor Recommended.
	Dr. Roopina Sangha, MD This Doctor is OpenDoctor Recommended.
	Dr. Wooju Jeong, MD This Doctor is OpenDoctor Recommended.
	Dr. Abd-El-Rahman M. Abd-El-Barr, MD
	Dr. David I. Eisenstein, MD
	Dr. Stefan H. Smietana, DO This Doctor is OpenDoctor Recommended.
	Dr. Barrett Anderson, DO
	Dr. Brandi D. Miller, DO
	Dr. Zachary J. Liss, MD
	Dr. Jay Jhaveri, MD
	Dr. Daniel M. Stein, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog